Daiichi Sankyo Unit To Co-Produce Measles-Rubella Vaccine In Vietnam
This article was originally published in PharmAsia News
Executive Summary
Kitasato Daiichi Sankyo Vaccine, an arm of the major Japan drug maker, plans to provide the technology for making a measles-rubella vaccine to Vietnam as part of a deal that includes building a production plant in the country.